Pennsylvania 2025_0 Regular Session Status: In Committee Bipartisan · 3 D · 3 R cosponsors

SB 826 — An Act amending the act of October 24, 2018 (P.L.719, No.112), known as the Patient Test Result Information Act, further providing for definitions; providing for Lyme disease testing disclosure; and imposing duties on health care practitioners.

Last action — Referred to HEALTH AND HUMAN SERVICES, June 3, 2025

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced June 03, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 42% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 6 sponsors

    1 primary, 5 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (3 D · 3 R) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Notification of False Negative results in Lyme Disease Lab Testing

Bill Text

We don't have the full text on file for this bill yet.

Read SB 826 on the official Pennsylvania source →

Action History

  1. Referred to HEALTH AND HUMAN SERVICES, June 3, 2025

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 5 co-sponsors · 247 not signed on

Sponsors (1)

Co-sponsors (5)

Not signed on (247)

247 members have not signed on to this bill.

Show all 247 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 826 do?
Notification of False Negative results in Lyme Disease Lab Testing
Who sponsors SB 826?
SB 826 is sponsored by Marty Flynn (Democratic), Camera Bartolotta (Republican), Lisa M. Boscola (Democratic), Greg Rothman (Republican), Daniel Laughlin (Republican), and Jay Costa (Democratic).
What is the current status of SB 826?
This bill is in committee in the Senate. Introduced June 03, 2025. It must pass committee before a floor vote.
Where can I track SB 826?
Track SB 826 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 826

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 826

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →